Activist investor Cevian takes stake in Swiss insurer Baloise
ZURICH, May 18 (Reuters) -Activist investor Cevian has taken a 3.12% stake in Swiss insurer Baloise BALN.S, the Swiss stock exchange said on Saturday. The stake would be worth around 213 million Swiss francs ($234 million) at current market prices, according to a Reuters calculation.
The exchange's statement comes after Baloise shareholders voted last month to scrap a 2% cap on voting rights, which had previously limited their influence on the company's management.
"We have followed Baloise for a long time and have invested as we see long-term value potential in the company," said a spokesman for Cevian.
"There is a significant opportunity to improve Baloise's operating performance and competitive position over the coming years," said the spokesman, who did not say when Cevian had started building its stake.
Cevian, which has offices in Stockholm, London and near Zurich, previously invested in Swiss engineering group ABB ABBN.S and last year reported a position in UBS UBSG.S, saying it wanted to double the value of its stake.
Baloise has endured a tough few years, with the Basel company's share price trailing rival insurers while investors have complained it is too dependent on its Swiss home market.
Over the past five years its stock has lost nearly 11% in value, lagging a 29% gain by the Stoxx Europe index for European insurers .SXIP.
A Baloise spokesperson said: "Like us, our investors see the long-term value potential of Baloise."
($1 = 0.9089 Swiss francs)
Reporting by Oliver Hirt; Writing by John Revill; Editing by David Holmes
免責聲明: XM Group提供線上交易平台的登入和執行服務，允許個人查看和/或使用網站所提供的內容，但不進行任何更改或擴展其服務和訪問權限，並受以下條款與條例約束：（i）條款與條例；（ii）風險提示；（iii）完全免責聲明。網站內部所提供的所有資訊，僅限於一般資訊用途。請注意，我們所有的線上交易平台內容並不構成，也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。
所有缐上交易平台所發佈的資料，僅適用於教育/資訊類用途，不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議，或是交易價格紀錄，或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。
本網站的所有XM和第三方所提供的内容，包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接，皆爲‘按原狀’，並作爲一般市場評論所提供，而非投資建議。請理解和接受，所有被歸類為投資研究範圍的相關内容，並非爲了促進投資研究獨立性，而根據法律要求所編寫，而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊，相關詳情請點擊 這裡查看。
